Regarding IL-17A, elevations have been detected in HBV, HCV, autoimmune hepatitis and primary biliary cirrhosis in which an IL-17A response is suggested to be disadvantageous [25], [28], [29], [30]. The gene discussed is IL17A; the disease is primary biliary cholangitis.